Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

bluebird bio Inc (NASDAQ:BLUE)

69.50
Delayed Data
As of Dec 09
 -2.30 / -3.20%
Today’s Change
35.37
Today|||52-Week Range
79.70
+8.22%
Year-to-Date
Better Buy: bluebird bio, Inc. vs. Kite Pharma
Dec 09 / MotleyFool.com - Paid Partner Content
Trump's Drug Pricing Comment Sends Biotech Stocks Into Free-fall
Dec 07 / TheStreet.com - Paid Partner Content
Why bluebird bio Inc. Slipped Lower Today
Dec 07 / MotleyFool.com - Paid Partner Content
Blood Work: A Few Biotech Thoughts from Sunny San Diego and the ASH 2016 Meeting
Dec 05 / TheStreet.com - Paid Partner Content
Biotech Only Sector in the Red as Trump Vows to Crackdown on Drug Pricing, Biggest Mo...
Dec 07 / TheStreet.com - Paid Partner Content
Why Celgene Shares Jumped 13.9% In November
Dec 05 / MotleyFool.com - Paid Partner Content
Why You Should Let Celgene Corporation Invest Your Money
Dec 07 / MotleyFool.com - Paid Partner Content
Why bluebird bio Shares Rallied 24.7% In November
Dec 03 / MotleyFool.com - Paid Partner Content
Dow, S&P 500 Trade at Session Highs in Broad Wall Street Rally
Dec 07 / TheStreet.com - Paid Partner Content
Adventures in CAR-T Racing: Crashes and Curves Edition
Dec 02 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close71.80
Today’s open72.45
Day’s range69.40 - 73.80
Volume1,127,442
Average volume (3 months)1,413,795
Market cap$2.9B
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-162.84%
Earnings growth (this year)-47.03%
Earnings growth (next 5 years)-23.75%
Revenue growth (last year)-44.62%
P/E ratioNM
Price/Sales158.14
Price/Book3.11

Competitors

 Today’s
change
Today’s
% change
ARIAARIAD Pharmaceutical...-0.30-2.31%
KITEKite Pharma Inc+0.82+1.82%
XONIntrexon Corp-0.52-1.71%
NBIXNeurocrine Bioscienc...-0.05-0.12%
Data as of 4:02pm ET, 12/09/2016

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)-$1.88
Annual revenue (last year)$14.1M
Annual profit (last year)-$166.8M
Net profit margin-1,184.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Nick Leschly
Chief Operating Officer
Susanna G. High
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs